Clinical Trial: A Study in Healthy Men and Women to Test Whether BI 1569912 Influences the Amount of Repaglinide, Midazolam and Bupropion in the Blood
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Healthy
Study Type: INTERVENTIONAL
Official Title: The Effect of Multiple Doses of BI 1569912 on the Single-dose Pharmacokinetics of Repaglinide, Midazolam and Bupropion Following Oral Administration in Healthy Male and Female Subjects (an Open-label,
Brief Summary:
The main objective of this trial is to investigate the effect of multiple oral doses of BI 1569912 on the pharmacokinetics of a single oral dose of repaglinide, midazolam and bupropion (i.e.sensitive CYP2C8, CYP3A4 and CYP2B6 substrates).
Read more